| Record Information |
|---|
| Version | 5.0 |
|---|
| Status | Expected but not Quantified |
|---|
| Creation Date | 2012-09-06 15:00:19 UTC |
|---|
| Update Date | 2021-09-14 15:00:47 UTC |
|---|
| HMDB ID | HMDB0013882 |
|---|
| Secondary Accession Numbers | |
|---|
| Metabolite Identification |
|---|
| Common Name | R-4'-Hydroxywarfarin |
|---|
| Description | R-4'-Hydroxywarfarin belongs to the class of organic compounds known as homoisoflavones. These are homoisoflavonoids with a structure based on the chromone system. Chromone is a bicyclic compound consisting of a 1-benzopyran, which bears a ketone group at the 4-position. R-4'-Hydroxywarfarin is only found in individuals that have used or taken Warfarin. R-4'-Hydroxywarfarin is an extremely weak basic (essentially neutral) compound (based on its pKa). |
|---|
| Structure | [H][C@@](CC(C)=O)(C1=CC=C(O)C=C1)C1=C(O)OC2=CC=CC=C2C1=O InChI=1S/C19H16O5/c1-11(20)10-15(12-6-8-13(21)9-7-12)17-18(22)14-4-2-3-5-16(14)24-19(17)23/h2-9,15,21,23H,10H2,1H3/t15-/m1/s1 |
|---|
| Synonyms | Not Available |
|---|
| Chemical Formula | C19H16O5 |
|---|
| Average Molecular Weight | 324.3273 |
|---|
| Monoisotopic Molecular Weight | 324.099773622 |
|---|
| IUPAC Name | 2-hydroxy-3-[(1R)-1-(4-hydroxyphenyl)-3-oxobutyl]-4H-chromen-4-one |
|---|
| Traditional Name | 2-hydroxy-3-[(1R)-1-(4-hydroxyphenyl)-3-oxobutyl]chromen-4-one |
|---|
| CAS Registry Number | Not Available |
|---|
| SMILES | [H][C@@](CC(C)=O)(C1=CC=C(O)C=C1)C1=C(O)OC2=CC=CC=C2C1=O |
|---|
| InChI Identifier | InChI=1S/C19H16O5/c1-11(20)10-15(12-6-8-13(21)9-7-12)17-18(22)14-4-2-3-5-16(14)24-19(17)23/h2-9,15,21,23H,10H2,1H3/t15-/m1/s1 |
|---|
| InChI Key | UNTPHJKCRGFOFJ-OAHLLOKOSA-N |
|---|
| Chemical Taxonomy |
|---|
| Description | Belongs to the class of organic compounds known as homoisoflavones. These are homoisoflavonoids with a structure based on the chromone system. Chromone is a bicyclic compound consisting of a 1-benzopyran, which bears a ketone group at the 4-position. |
|---|
| Kingdom | Organic compounds |
|---|
| Super Class | Phenylpropanoids and polyketides |
|---|
| Class | Homoisoflavonoids |
|---|
| Sub Class | Homoisoflavones |
|---|
| Direct Parent | Homoisoflavones |
|---|
| Alternative Parents | |
|---|
| Substituents | - Homoisoflavone
- Chromone
- Coumarin
- Benzopyran
- 1-benzopyran
- 1-hydroxy-2-unsubstituted benzenoid
- Phenol
- Pyranone
- Monocyclic benzene moiety
- Pyran
- Benzenoid
- Heteroaromatic compound
- Vinylogous acid
- Ketone
- Organoheterocyclic compound
- Oxacycle
- Organooxygen compound
- Hydrocarbon derivative
- Organic oxide
- Carbonyl group
- Organic oxygen compound
- Aromatic heteropolycyclic compound
|
|---|
| Molecular Framework | Aromatic heteropolycyclic compounds |
|---|
| External Descriptors | Not Available |
|---|
| Ontology |
|---|
| Physiological effect | Not Available |
|---|
| Disposition | |
|---|
| Process | Not Available |
|---|
| Role | Not Available |
|---|
| Physical Properties |
|---|
| State | Not Available |
|---|
| Experimental Molecular Properties | | Property | Value | Reference |
|---|
| Melting Point | Not Available | Not Available | | Boiling Point | Not Available | Not Available | | Water Solubility | Not Available | Not Available | | LogP | Not Available | Not Available |
|
|---|
| Experimental Chromatographic Properties | Not Available |
|---|
| Predicted Molecular Properties | |
|---|
| Predicted Chromatographic Properties | Predicted Collision Cross SectionsPredicted Retention Times Underivatized| Chromatographic Method | Retention Time | Reference |
|---|
| Measured using a Waters Acquity ultraperformance liquid chromatography (UPLC) ethylene-bridged hybrid (BEH) C18 column (100 mm × 2.1 mm; 1.7 μmparticle diameter). Predicted by Afia on May 17, 2022. Predicted by Afia on May 17, 2022. | 7.91 minutes | 32390414 | | Predicted by Siyang on May 30, 2022 | 12.0019 minutes | 33406817 | | Predicted by Siyang using ReTip algorithm on June 8, 2022 | 0.96 minutes | 32390414 | | AjsUoB = Accucore 150 Amide HILIC with 10mM Ammonium Formate, 0.1% Formic Acid | 34.8 seconds | 40023050 | | Fem_Long = Waters ACQUITY UPLC HSS T3 C18 with Water:MeOH and 0.1% Formic Acid | 1710.8 seconds | 40023050 | | Fem_Lipids = Ascentis Express C18 with (60:40 water:ACN):(90:10 IPA:ACN) and 10mM NH4COOH + 0.1% Formic Acid | 241.9 seconds | 40023050 | | Life_Old = Waters ACQUITY UPLC BEH C18 with Water:(20:80 acetone:ACN) and 0.1% Formic Acid | 161.6 seconds | 40023050 | | Life_New = RP Waters ACQUITY UPLC HSS T3 C18 with Water:(30:70 MeOH:ACN) and 0.1% Formic Acid | 165.9 seconds | 40023050 | | RIKEN = Waters ACQUITY UPLC BEH C18 with Water:ACN and 0.1% Formic Acid | 111.1 seconds | 40023050 | | Eawag_XBridgeC18 = XBridge C18 3.5u 2.1x50 mm with Water:MeOH and 0.1% Formic Acid | 455.2 seconds | 40023050 | | BfG_NTS_RP1 =Agilent Zorbax Eclipse Plus C18 (2.1 mm x 150 mm, 3.5 um) with Water:ACN and 0.1% Formic Acid | 432.4 seconds | 40023050 | | HILIC_BDD_2 = Merck SeQuant ZIC-HILIC with ACN(0.1% formic acid):water(16 mM ammonium formate) | 132.2 seconds | 40023050 | | UniToyama_Atlantis = RP Waters Atlantis T3 (2.1 x 150 mm, 5 um) with ACN:Water and 0.1% Formic Acid | 908.3 seconds | 40023050 | | BDD_C18 = Hypersil Gold 1.9µm C18 with Water:ACN and 0.1% Formic Acid | 413.5 seconds | 40023050 | | UFZ_Phenomenex = Kinetex Core-Shell C18 2.6 um, 3.0 x 100 mm, Phenomenex with Water:MeOH and 0.1% Formic Acid | 1246.5 seconds | 40023050 | | SNU_RIKEN_POS = Waters ACQUITY UPLC BEH C18 with Water:ACN and 0.1% Formic Acid | 301.6 seconds | 40023050 | | RPMMFDA = Waters ACQUITY UPLC BEH C18 with Water:ACN and 0.1% Formic Acid | 323.0 seconds | 40023050 | | MTBLS87 = Merck SeQuant ZIC-pHILIC column with ACN:Water and :ammonium carbonate | 313.4 seconds | 40023050 | | KI_GIAR_zic_HILIC_pH2_7 = Merck SeQuant ZIC-HILIC with ACN:Water and 0.1% FA | 219.7 seconds | 40023050 | | Meister zic-pHILIC pH9.3 = Merck SeQuant ZIC-pHILIC column with ACN:Water 5mM NH4Ac pH9.3 and 5mM ammonium acetate in water | 54.6 seconds | 40023050 |
Predicted Kovats Retention IndicesUnderivatizedDerivatized| Derivative Name / Structure | SMILES | Kovats RI Value | Column Type | Reference |
|---|
| R-4'-Hydroxywarfarin,1TMS,isomer #1 | CC(=O)C[C@H](C1=CC=C(O[Si](C)(C)C)C=C1)C1=C(O)OC2=CC=CC=C2C1=O | 2928.9 | Semi standard non polar | 33892256 | | R-4'-Hydroxywarfarin,1TMS,isomer #2 | CC(=O)C[C@H](C1=CC=C(O)C=C1)C1=C(O[Si](C)(C)C)OC2=CC=CC=C2C1=O | 3035.9 | Semi standard non polar | 33892256 | | R-4'-Hydroxywarfarin,1TMS,isomer #3 | CC(=C[C@H](C1=CC=C(O)C=C1)C1=C(O)OC2=CC=CC=C2C1=O)O[Si](C)(C)C | 3143.1 | Semi standard non polar | 33892256 | | R-4'-Hydroxywarfarin,1TMS,isomer #4 | C=C(C[C@H](C1=CC=C(O)C=C1)C1=C(O)OC2=CC=CC=C2C1=O)O[Si](C)(C)C | 3078.6 | Semi standard non polar | 33892256 | | R-4'-Hydroxywarfarin,2TMS,isomer #1 | CC(=O)C[C@H](C1=CC=C(O[Si](C)(C)C)C=C1)C1=C(O[Si](C)(C)C)OC2=CC=CC=C2C1=O | 2990.4 | Semi standard non polar | 33892256 | | R-4'-Hydroxywarfarin,2TMS,isomer #2 | CC(=C[C@H](C1=CC=C(O[Si](C)(C)C)C=C1)C1=C(O)OC2=CC=CC=C2C1=O)O[Si](C)(C)C | 3056.1 | Semi standard non polar | 33892256 | | R-4'-Hydroxywarfarin,2TMS,isomer #3 | C=C(C[C@H](C1=CC=C(O[Si](C)(C)C)C=C1)C1=C(O)OC2=CC=CC=C2C1=O)O[Si](C)(C)C | 2988.2 | Semi standard non polar | 33892256 | | R-4'-Hydroxywarfarin,2TMS,isomer #4 | CC(=C[C@H](C1=CC=C(O)C=C1)C1=C(O[Si](C)(C)C)OC2=CC=CC=C2C1=O)O[Si](C)(C)C | 3064.4 | Semi standard non polar | 33892256 | | R-4'-Hydroxywarfarin,2TMS,isomer #5 | C=C(C[C@H](C1=CC=C(O)C=C1)C1=C(O[Si](C)(C)C)OC2=CC=CC=C2C1=O)O[Si](C)(C)C | 3016.0 | Semi standard non polar | 33892256 | | R-4'-Hydroxywarfarin,3TMS,isomer #1 | CC(=C[C@H](C1=CC=C(O[Si](C)(C)C)C=C1)C1=C(O[Si](C)(C)C)OC2=CC=CC=C2C1=O)O[Si](C)(C)C | 3099.0 | Semi standard non polar | 33892256 | | R-4'-Hydroxywarfarin,3TMS,isomer #1 | CC(=C[C@H](C1=CC=C(O[Si](C)(C)C)C=C1)C1=C(O[Si](C)(C)C)OC2=CC=CC=C2C1=O)O[Si](C)(C)C | 3052.0 | Standard non polar | 33892256 | | R-4'-Hydroxywarfarin,3TMS,isomer #1 | CC(=C[C@H](C1=CC=C(O[Si](C)(C)C)C=C1)C1=C(O[Si](C)(C)C)OC2=CC=CC=C2C1=O)O[Si](C)(C)C | 3274.3 | Standard polar | 33892256 | | R-4'-Hydroxywarfarin,3TMS,isomer #2 | C=C(C[C@H](C1=CC=C(O[Si](C)(C)C)C=C1)C1=C(O[Si](C)(C)C)OC2=CC=CC=C2C1=O)O[Si](C)(C)C | 3023.3 | Semi standard non polar | 33892256 | | R-4'-Hydroxywarfarin,3TMS,isomer #2 | C=C(C[C@H](C1=CC=C(O[Si](C)(C)C)C=C1)C1=C(O[Si](C)(C)C)OC2=CC=CC=C2C1=O)O[Si](C)(C)C | 2866.0 | Standard non polar | 33892256 | | R-4'-Hydroxywarfarin,3TMS,isomer #2 | C=C(C[C@H](C1=CC=C(O[Si](C)(C)C)C=C1)C1=C(O[Si](C)(C)C)OC2=CC=CC=C2C1=O)O[Si](C)(C)C | 3270.5 | Standard polar | 33892256 | | R-4'-Hydroxywarfarin,1TBDMS,isomer #1 | CC(=O)C[C@H](C1=CC=C(O[Si](C)(C)C(C)(C)C)C=C1)C1=C(O)OC2=CC=CC=C2C1=O | 3190.2 | Semi standard non polar | 33892256 | | R-4'-Hydroxywarfarin,1TBDMS,isomer #2 | CC(=O)C[C@H](C1=CC=C(O)C=C1)C1=C(O[Si](C)(C)C(C)(C)C)OC2=CC=CC=C2C1=O | 3289.4 | Semi standard non polar | 33892256 | | R-4'-Hydroxywarfarin,1TBDMS,isomer #3 | CC(=C[C@H](C1=CC=C(O)C=C1)C1=C(O)OC2=CC=CC=C2C1=O)O[Si](C)(C)C(C)(C)C | 3401.5 | Semi standard non polar | 33892256 | | R-4'-Hydroxywarfarin,1TBDMS,isomer #4 | C=C(C[C@H](C1=CC=C(O)C=C1)C1=C(O)OC2=CC=CC=C2C1=O)O[Si](C)(C)C(C)(C)C | 3350.1 | Semi standard non polar | 33892256 | | R-4'-Hydroxywarfarin,2TBDMS,isomer #1 | CC(=O)C[C@H](C1=CC=C(O[Si](C)(C)C(C)(C)C)C=C1)C1=C(O[Si](C)(C)C(C)(C)C)OC2=CC=CC=C2C1=O | 3457.6 | Semi standard non polar | 33892256 | | R-4'-Hydroxywarfarin,2TBDMS,isomer #2 | CC(=C[C@H](C1=CC=C(O[Si](C)(C)C(C)(C)C)C=C1)C1=C(O)OC2=CC=CC=C2C1=O)O[Si](C)(C)C(C)(C)C | 3614.5 | Semi standard non polar | 33892256 | | R-4'-Hydroxywarfarin,2TBDMS,isomer #3 | C=C(C[C@H](C1=CC=C(O[Si](C)(C)C(C)(C)C)C=C1)C1=C(O)OC2=CC=CC=C2C1=O)O[Si](C)(C)C(C)(C)C | 3525.0 | Semi standard non polar | 33892256 | | R-4'-Hydroxywarfarin,2TBDMS,isomer #4 | CC(=C[C@H](C1=CC=C(O)C=C1)C1=C(O[Si](C)(C)C(C)(C)C)OC2=CC=CC=C2C1=O)O[Si](C)(C)C(C)(C)C | 3582.5 | Semi standard non polar | 33892256 | | R-4'-Hydroxywarfarin,2TBDMS,isomer #5 | C=C(C[C@H](C1=CC=C(O)C=C1)C1=C(O[Si](C)(C)C(C)(C)C)OC2=CC=CC=C2C1=O)O[Si](C)(C)C(C)(C)C | 3523.4 | Semi standard non polar | 33892256 | | R-4'-Hydroxywarfarin,3TBDMS,isomer #1 | CC(=C[C@H](C1=CC=C(O[Si](C)(C)C(C)(C)C)C=C1)C1=C(O[Si](C)(C)C(C)(C)C)OC2=CC=CC=C2C1=O)O[Si](C)(C)C(C)(C)C | 3837.1 | Semi standard non polar | 33892256 | | R-4'-Hydroxywarfarin,3TBDMS,isomer #1 | CC(=C[C@H](C1=CC=C(O[Si](C)(C)C(C)(C)C)C=C1)C1=C(O[Si](C)(C)C(C)(C)C)OC2=CC=CC=C2C1=O)O[Si](C)(C)C(C)(C)C | 3620.0 | Standard non polar | 33892256 | | R-4'-Hydroxywarfarin,3TBDMS,isomer #1 | CC(=C[C@H](C1=CC=C(O[Si](C)(C)C(C)(C)C)C=C1)C1=C(O[Si](C)(C)C(C)(C)C)OC2=CC=CC=C2C1=O)O[Si](C)(C)C(C)(C)C | 3523.0 | Standard polar | 33892256 | | R-4'-Hydroxywarfarin,3TBDMS,isomer #2 | C=C(C[C@H](C1=CC=C(O[Si](C)(C)C(C)(C)C)C=C1)C1=C(O[Si](C)(C)C(C)(C)C)OC2=CC=CC=C2C1=O)O[Si](C)(C)C(C)(C)C | 3712.1 | Semi standard non polar | 33892256 | | R-4'-Hydroxywarfarin,3TBDMS,isomer #2 | C=C(C[C@H](C1=CC=C(O[Si](C)(C)C(C)(C)C)C=C1)C1=C(O[Si](C)(C)C(C)(C)C)OC2=CC=CC=C2C1=O)O[Si](C)(C)C(C)(C)C | 3420.6 | Standard non polar | 33892256 | | R-4'-Hydroxywarfarin,3TBDMS,isomer #2 | C=C(C[C@H](C1=CC=C(O[Si](C)(C)C(C)(C)C)C=C1)C1=C(O[Si](C)(C)C(C)(C)C)OC2=CC=CC=C2C1=O)O[Si](C)(C)C(C)(C)C | 3532.6 | Standard polar | 33892256 |
|
|---|
| GC-MS Spectra| Spectrum Type | Description | Splash Key | Deposition Date | Source | View |
|---|
| Predicted GC-MS | Predicted GC-MS Spectrum - R-4'-Hydroxywarfarin GC-MS (Non-derivatized) - 70eV, Positive | splash10-0006-9483000000-36dc1d79b3ca01daa859 | 2017-09-01 | Wishart Lab | View Spectrum | | Predicted GC-MS | Predicted GC-MS Spectrum - R-4'-Hydroxywarfarin GC-MS (2 TMS) - 70eV, Positive | splash10-0fk9-4319500000-068a7802c5307c0289ef | 2017-10-06 | Wishart Lab | View Spectrum | | Predicted GC-MS | Predicted GC-MS Spectrum - R-4'-Hydroxywarfarin GC-MS (Non-derivatized) - 70eV, Positive | Not Available | 2021-10-12 | Wishart Lab | View Spectrum |
MS/MS Spectra| Spectrum Type | Description | Splash Key | Deposition Date | Source | View |
|---|
| Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - R-4'-Hydroxywarfarin 10V, Positive-QTOF | splash10-056r-0029000000-be7201de94e1177ea7ad | 2016-08-01 | Wishart Lab | View Spectrum | | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - R-4'-Hydroxywarfarin 20V, Positive-QTOF | splash10-0a6r-0289000000-5e41e3dfa32493c90dd6 | 2016-08-01 | Wishart Lab | View Spectrum | | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - R-4'-Hydroxywarfarin 40V, Positive-QTOF | splash10-00kr-1491000000-9ed711ac5ac00511997a | 2016-08-01 | Wishart Lab | View Spectrum | | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - R-4'-Hydroxywarfarin 10V, Negative-QTOF | splash10-00fr-1079000000-796fb9be3b5d541866b0 | 2016-08-03 | Wishart Lab | View Spectrum | | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - R-4'-Hydroxywarfarin 20V, Negative-QTOF | splash10-0729-3596000000-a5a95101e145e6b38bc8 | 2016-08-03 | Wishart Lab | View Spectrum | | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - R-4'-Hydroxywarfarin 40V, Negative-QTOF | splash10-06tf-9380000000-062dc5d03fb1f193ce35 | 2016-08-03 | Wishart Lab | View Spectrum | | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - R-4'-Hydroxywarfarin 10V, Negative-QTOF | splash10-00di-0209000000-3edc362c6c066783b1d5 | 2021-09-24 | Wishart Lab | View Spectrum | | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - R-4'-Hydroxywarfarin 20V, Negative-QTOF | splash10-03di-4924000000-9e07395e75595d9d7855 | 2021-09-24 | Wishart Lab | View Spectrum | | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - R-4'-Hydroxywarfarin 40V, Negative-QTOF | splash10-014l-7910000000-0aefb176aedab515621d | 2021-09-24 | Wishart Lab | View Spectrum | | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - R-4'-Hydroxywarfarin 10V, Positive-QTOF | splash10-03fr-0918000000-9eba5ce7ad9f97a6f68e | 2021-09-24 | Wishart Lab | View Spectrum | | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - R-4'-Hydroxywarfarin 20V, Positive-QTOF | splash10-03di-0921000000-8966ce1a927b1a5c00b5 | 2021-09-24 | Wishart Lab | View Spectrum | | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - R-4'-Hydroxywarfarin 40V, Positive-QTOF | splash10-00dr-2921000000-274299d4a1ddb4847add | 2021-09-24 | Wishart Lab | View Spectrum |
|
|---|